The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Schistosomiasis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Schistosomiasis

 

High impact information on Schistosomiasis

 

Chemical compound and disease context of Schistosomiasis

 

Biological context of Schistosomiasis

 

Anatomical context of Schistosomiasis

 

Gene context of Schistosomiasis

 

Analytical, diagnostic and therapeutic context of Schistosomiasis

References

  1. IL-13 effector functions. Wynn, T.A. Annu. Rev. Immunol. (2003) [Pubmed]
  2. Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoni. Khalife, J., Grzych, J.M., Pierce, R., Ameisen, J.C., Schacht, A.M., Gras-Masse, H., Tartar, A., Lecocq, J.P., Capron, A. J. Exp. Med. (1990) [Pubmed]
  3. Immune complex nephropathy i schistosomiasis. Falcão, H.A., Gould, D.B. Ann. Intern. Med. (1975) [Pubmed]
  4. Proline trapping in granulomas, the site of collagen biosynthesis in murine schistosomiasis. Dunn, M.A., Seifter, S., Hait, P.K. Hepatology (1981) [Pubmed]
  5. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Chiaramonte, M.G., Cheever, A.W., Malley, J.D., Donaldson, D.D., Wynn, T.A. Hepatology (2001) [Pubmed]
  6. Letter: Schistosomiasis, immunosuppression and niridazole. Higashi, G.I., Gheith, H., Farid, Z., Miner, W.F. N. Engl. J. Med. (1975) [Pubmed]
  7. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. Angeli, V., Faveeuw, C., Roye, O., Fontaine, J., Teissier, E., Capron, A., Wolowczuk, I., Capron, M., Trottein, F. J. Exp. Med. (2001) [Pubmed]
  8. CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. Jankovic, D., Cheever, A.W., Kullberg, M.C., Wynn, T.A., Yap, G., Caspar, P., Lewis, F.A., Clynes, R., Ravetch, J.V., Sher, A. J. Exp. Med. (1998) [Pubmed]
  9. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. Sarin, S.K., Groszmann, R.J., Mosca, P.G., Rojkind, M., Stadecker, M.J., Bhatnagar, R., Reuben, A., Dayal, Y. J. Clin. Invest. (1991) [Pubmed]
  10. Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen. Kresina, T.F., Olds, G.R. J. Clin. Invest. (1989) [Pubmed]
  11. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. Webster, L.T., Butterworth, A.E., Mahmoud, A.A., Mngola, E.N., Warren, K.S. N. Engl. J. Med. (1975) [Pubmed]
  12. Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease control with oxamniquine. Sleigh, A.C., Hoff, R., Mott, K.E., Maguire, J.H., da França Silva, J.T. Lancet (1986) [Pubmed]
  13. Scales modified for dose determination in population-based chemotherapy. Jack, A., Bradley, D. Lancet (1991) [Pubmed]
  14. Conversion of arginine to proline in murine schistosomiasis. Dunn, M.A., Rojkind, M., Hait, P.K., Warren, K.S. Gastroenterology (1978) [Pubmed]
  15. Alteration of the granulomatous response in murine schistosomiasis by the chronic administration of captopril, an inhibitor of angiotensin-converting enzyme. Weinstock, J.V., Boros, D.L. Gastroenterology (1981) [Pubmed]
  16. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. Flores Villanueva, P.O., Reiser, H., Stadecker, M.J. J. Immunol. (1994) [Pubmed]
  17. IL-2 contributes to the IL-5 response in granulomas from mice infected with Schistosoma mansoni. Metwali, A., Elliott, D., Mathew, R., Blum, A., Weinstock, J.V. J. Immunol. (1993) [Pubmed]
  18. Streptozotocin-induced diabetes mellitus and the host-parasite relation in murine schistosomiasis mansoni. Mahmoud, A.A., Cheever, A.W., Warren, K.S. J. Infect. Dis. (1975) [Pubmed]
  19. Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice. Faveeuw, C., Mallevaey, T., Paschinger, K., Wilson, I.B., Fontaine, J., Mollicone, R., Oriol, R., Altmann, F., Lerouge, P., Capron, M., Trottein, F. Eur. J. Immunol. (2003) [Pubmed]
  20. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium. El Ridi, R., Farouk, F., Sherif, M., Al-Sherbiny, M., Osman, A., El Gengehi, N., Shoemaker, C.B. J. Infect. Dis. (1998) [Pubmed]
  21. Schistosomiasis in Lake Malawi. Cetron, M.S., Chitsulo, L., Sullivan, J.J., Pilcher, J., Wilson, M., Noh, J., Tsang, V.C., Hightower, A.W., Addiss, D.G. Lancet (1996) [Pubmed]
  22. Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Rutitzky, L.I., Hernandez, H.J., Stadecker, M.J. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  23. IL-4 regulates VIP receptor subtype 2 mRNA (VPAC2) expression in T cells in murine schistosomiasis. Metwali, A., Blum, A.M., Li, J., Elliott, D.E., Weinstock, J.V. FASEB J. (2000) [Pubmed]
  24. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. Rumbley, C.A., Sugaya, H., Zekavat, S.A., El Refaei, M., Perrin, P.J., Phillips, S.M. J. Immunol. (1999) [Pubmed]
  25. Fibroblast stimulation in schistosomiasis. XI. Purification to apparent homogeneity of fibroblast-stimulating factor-1, an acidic heparin-binding growth factor produced by schistosomal egg granulomas. Prakash, S., Wyler, D.J. J. Immunol. (1991) [Pubmed]
  26. Interleukin 12 and antigen independently induce substance P receptor expression in T cells in murine schistosomiasis mansoni. Blum, A.M., Metwali, A., Crawford, C., Li, J., Qadir, K., Elliott, D.E., Weinstock, J.V. FASEB J. (2001) [Pubmed]
  27. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. Metwali, A., Elliott, D., Blum, A.M., Li, J., Sandor, M., Lynch, R., Noben-Trauth, N., Weinstock, J.V. J. Immunol. (1996) [Pubmed]
  28. Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni. Blum, A.M., Metwali, A., Cook, G., Mathew, R.C., Elliott, D., Weinstock, J.V. J. Immunol. (1993) [Pubmed]
  29. Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. Vaillant, B., Chiaramonte, M.G., Cheever, A.W., Soloway, P.D., Wynn, T.A. J. Immunol. (2001) [Pubmed]
  30. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. Hesse, M., Modolell, M., La Flamme, A.C., Schito, M., Fuentes, J.M., Cheever, A.W., Pearce, E.J., Wynn, T.A. J. Immunol. (2001) [Pubmed]
  31. Radioallergosorbent and indirect fluorescent antibody tests in immunodiagnosis of schistosomiasis. Weiss, N., Stürchler, D., Dietrich, F.M. Lancet (1978) [Pubmed]
  32. Analysis and preliminary purification of glycoproteins isolated from eggs in the urine of patients with Schistosoma haematobium infection. Hamburger, J., Lustigman, S., Siongok, T.K., Ouma, J.H., Mahmoud, A.A. J. Immunol. (1982) [Pubmed]
  33. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. Hesse, M., Piccirillo, C.A., Belkaid, Y., Prufer, J., Mentink-Kane, M., Leusink, M., Cheever, A.W., Shevach, E.M., Wynn, T.A. J. Immunol. (2004) [Pubmed]
  34. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. Mwatha, J.K., Kimani, G., Kamau, T., Mbugua, G.G., Ouma, J.H., Mumo, J., Fulford, A.J., Jones, F.M., Butterworth, A.E., Roberts, M.B., Dunne, D.W. J. Immunol. (1998) [Pubmed]
  35. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Wynn, T.A., Hoffmann, K.F. Parasitol. Today (Regul. Ed.) (2000) [Pubmed]
 
WikiGenes - Universities